IPP Bureau
India welcomes TRIPS waiver deal at WTO
By IPP Bureau - June 21, 2022
TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture COVID vaccines to deal with the pandemic
Unilever, Genomatica form venture to develop palm oil based alternatives
By IPP Bureau - June 20, 2022
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Cipla signs agreement for acquisition of 21.05% stake in Achira Labs
By IPP Bureau - June 20, 2022
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Aurobindo Pharma board approves acquisition of GLS Pharma
By IPP Bureau - June 20, 2022
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
Polio Sub-National Immunization Day to be conducted from 19th June 2022
By IPP Bureau - June 20, 2022
The states where Polio vaccine drops will be conducted includes: Bihar, Chandigarh, Delhi, Gujarat, Haryana, Jharkhand, Maharashtra, Punjab, Rajasthan, Uttarakhand, and West Bengal
Aether Industries Q4 FY22 revenue up 26.8%; Profit up 13.8%
By IPP Bureau - June 18, 2022
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation
By IPP Bureau - June 18, 2022
Both manufacturing facilities are based out of Benguluru, India
Revelation Pharma completes 8th acquisition
By IPP Bureau - June 17, 2022
Wedgewood Pharmacy operates compounding pharmacies that offers sterile and non-sterile compounded medications for animal patients in 50 states.
GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer
By IPP Bureau - June 17, 2022
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Valo Therapeutics appoints Hemanshu Shah as Chief Business Officer
By IPP Bureau - June 17, 2022
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Saint-Gobain Life Sciences expands manufacturing facility in Japan
By IPP Bureau - June 17, 2022
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute
By IPP Bureau - June 16, 2022
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Dolomite Bio releases hydrogel reagent kits for agarose encapsulation and 3D cell culture research
By IPP Bureau - June 16, 2022
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
Sir H N Reliance Foundation Hospital performs India’s first Sapien3 Tricuspid implant
By IPP Bureau - June 16, 2022
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
Syntegra partners with TMA Precision to reduce the diagnostic odyssey for rare disease with synthetic data-enabled tools
By IPP Bureau - June 16, 2022
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
